The Pfizer-Biontech Vaccine: Firstcomers and Latecomers

In a paper I’ve mentioned here before, Pierre LeMorvan and Barbara Stock discuss a moral dilemma that arises from the ubiquity, in health care, of what they call “the medical learning curve.” The idea is that neophyte health care workers face a learning curve that puts patients at risk: the earlier I am in my career as a health care worker, the less skilled and knowledgeable I’m apt to be, and the more prone to error. The more error-prone I am, the more likely to impose medically dangerous risks on patients. Since health care workers need to practice their knowledge and skills on patients in order to achieve proficiency, this situation is ineliminable, even with the best supervision by more experienced practitioners. Continue reading